mTOR Inhibitors Market Poised for Steady Growth - Expected to Reach $7.11 Billion in 2023
Retrieved on:
Monday, September 18, 2023
GSK, Laboratory, Ciba-Geigy Canada Ltd v Apotex Inc, AbbVie, Exelixis, Agriculture, COVID-19, Pfizer, Merck & Co., Alkem Laboratories, AstraZeneca, GSK plc, Compound annual growth rate, Endo International, Bristol Myers Squibb, Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective, Microsoft Excel, Eli Lilly and Company, Merck, Country, Novartis, Pharmaceutical industry, Retail
DUBLIN, Sept. 18, 2023 /PRNewswire/ -- The "mTOR Inhibitors Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
Key Points:
- DUBLIN, Sept. 18, 2023 /PRNewswire/ -- The "mTOR Inhibitors Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
- The global mTOR inhibitors market is on a steady growth path, with an expected increase from $6.70 billion in 2022 to $7.11 billion in 2023, reflecting a Compound Annual Growth Rate (CAGR) of 6.05%.
- This growth trajectory is set to continue, reaching $8.76 billion by 2027 at a CAGR of 5.38%.
- Inflation Analysis: Measure the influence of high global inflation on market growth.